Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Joel I Reisman

Biographic Data

ID5534423
NAMEJoel I Reisman
GIVEN NAMESJoel I
FAMILY NAMEReisman
SIGNATUREREISMAN J I
AFFILIATIONSCenter for Health Optimization and Implementation Research
ORCID0000-0002-0552-161X
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS3
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR1992
LATEST PUBLICATION YEAR2025
H-INDEX1
  • Development of a Surveillance System to Identify Incidence of Evictions Among Patients in Veterans Affairs Medical Centers Across the United States

    Open Access•Joyce Tsai, Suja S Rajan et al.•ARTICLE•Journal of Community Health•2025

  • Using Self-Identified Gender Identity Data to Advance Health Equity Among Transgender and Gender Diverse Veterans in the Veterans Health Administration

    Guneet K Jasuja, Mark S Zocchi et al.•ARTICLE•Medical Care•2025•References: 35

    BACKGROUND: Identification of transgender and gender diverse (TGD) people has been limited to diagnoses and text rather than self-identified gender identity (SIGI), representing a subset of TGD people. In 2017, the Veterans Health Administration (VHA) implemented SIGI, allowing for precise identification of TGD veterans, including subgroups (transgender man, transgender woman, and nonbinary). OBJECTIVES: Health conditions, adverse social determin…

  • Leveraging Electronic Health Record Data to Identify Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Veteran Participants in the Pride in All Who Served Program

    Guneet K Jasuja, Joel I Reisman et al.•ARTICLE•Medical Care•2025•References: 35

    BACKGROUND: Pride in All Who Served (PRIDE) is an intervention in the Veterans Health Administration (VHA) focused on enhancing Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) veterans' access to affirmative care services, social support, and engagement with VHA. Evaluation of PRIDE to date has focused on self-report data, missing critical opportunities to examine the impact of this program on health outcomes and utilization indicators de…

  • The relationship between gastrointestinal symptom attribution, bothersomeness, and antiretroviral adherence among adults with HIV

    Holly Swan, Joel I Reisman et al.•ARTICLE•AIDS Care•2018

    Patients who attribute their symptoms to HIV medications, rather than disease, may be prone to switching antiretrovirals (ARVs) and experience poor retention/adherence to care. Gastrointestinal (GI) symptoms (e.g., nausea/vomiting) are often experienced as a side effect of ARVs, but little is known about the relationship of symptom attribution and bothersomeness to adherence. We hypothesized that attribution of a GI symptom to ARVs is associated …

  • Use of testosterone in men infected with human immunodeficiency virus in the veterans healthcare system

    Guneet K Jasuja, Shalender Bhasin et al.•ARTICLE•AIDS Care•2018

    Testosterone supplementation has been widely used in those infected with human immunodeficiency virus (HIV) for hypogonadism, and wasting. But with effective antiretroviral therapy and increasing recognition of atherosclerotic disease and adults infected with HIV, the risks of inappropriate testosterone use in HIV-infected patients are far better recognized than previously. Testosterone use has expanded among U.S. males, but few studies have exam…

  • Ascertainment of Testosterone Prescribing Practices in the VA

    Guneet K Jasuja, Shalender Bhasin et al.•ARTICLE•Medical Care•2015•References: 25

    BACKGROUND: Prescribing of exogenous testosterone is increasing. Because of the risks associated with testosterone, it is important to follow evidence-based procedures when initiating therapy. OBJECTIVE: We evaluated whether dispensing of testosterone was preceded by appropriate ascertainment of androgen deficiency, and consideration of potential contraindications, in accordance with practice guidelines. RESEARCH DESIGN: A cross-sectional study. …

  • Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program

    Stephen Havas, R Bishop et al.•ARTICLE•American Journal of Public Health•1992•Cited by: 3•References: 15

    The precision, accuracy, and durability of the Reflotron were evaluated by the Massachusetts Model Systems for Blood Cholesterol Screening Program. Screenings were conducted in diverse community settings over 16 months. Fingerstick samples from 10,428 individuals were tested. None of the four analyzers met the 1992 standards for precision, although two met the 1992 standards for accuracy. More than 40% of Reflotron values differed from the refere…

  • Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program

    Stephen Havas, R Bishop et al.•ARTICLE•American Journal of Public Health•1992•Cited by: 3•References: 15

    The precision, accuracy, and durability of the Reflotron were evaluated by the Massachusetts Model Systems for Blood Cholesterol Screening Program. Screenings were conducted in diverse community settings over 16 months. Fingerstick samples from 10,428 individuals were tested. None of the four analyzers met the 1992 standards for precision, although two met the 1992 standards for accuracy. More than 40% of Reflotron values differed from the refere…

  • Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program

    Stephen Havas, R Bishop et al.•ARTICLE•American Journal of Public Health•1992•Cited by: 3•References: 15

    The precision, accuracy, and durability of the Reflotron were evaluated by the Massachusetts Model Systems for Blood Cholesterol Screening Program. Screenings were conducted in diverse community settings over 16 months. Fingerstick samples from 10,428 individuals were tested. None of the four analyzers met the 1992 standards for precision, although two met the 1992 standards for accuracy. More than 40% of Reflotron values differed from the refere…

  • Ascertainment of Testosterone Prescribing Practices in the VA

    Guneet K Jasuja, Shalender Bhasin et al.•ARTICLE•Medical Care•2015•References: 25

    BACKGROUND: Prescribing of exogenous testosterone is increasing. Because of the risks associated with testosterone, it is important to follow evidence-based procedures when initiating therapy. OBJECTIVE: We evaluated whether dispensing of testosterone was preceded by appropriate ascertainment of androgen deficiency, and consideration of potential contraindications, in accordance with practice guidelines. RESEARCH DESIGN: A cross-sectional study. …

  • The relationship between gastrointestinal symptom attribution, bothersomeness, and antiretroviral adherence among adults with HIV

    Holly Swan, Joel I Reisman et al.•ARTICLE•AIDS Care•2018

    Patients who attribute their symptoms to HIV medications, rather than disease, may be prone to switching antiretrovirals (ARVs) and experience poor retention/adherence to care. Gastrointestinal (GI) symptoms (e.g., nausea/vomiting) are often experienced as a side effect of ARVs, but little is known about the relationship of symptom attribution and bothersomeness to adherence. We hypothesized that attribution of a GI symptom to ARVs is associated …

  • Use of testosterone in men infected with human immunodeficiency virus in the veterans healthcare system

    Guneet K Jasuja, Shalender Bhasin et al.•ARTICLE•AIDS Care•2018

    Testosterone supplementation has been widely used in those infected with human immunodeficiency virus (HIV) for hypogonadism, and wasting. But with effective antiretroviral therapy and increasing recognition of atherosclerotic disease and adults infected with HIV, the risks of inappropriate testosterone use in HIV-infected patients are far better recognized than previously. Testosterone use has expanded among U.S. males, but few studies have exam…

  • Development of a Surveillance System to Identify Incidence of Evictions Among Patients in Veterans Affairs Medical Centers Across the United States

    Open Access•Joyce Tsai, Suja S Rajan et al.•ARTICLE•Journal of Community Health•2025

  • Using Self-Identified Gender Identity Data to Advance Health Equity Among Transgender and Gender Diverse Veterans in the Veterans Health Administration

    Guneet K Jasuja, Mark S Zocchi et al.•ARTICLE•Medical Care•2025•References: 35

    BACKGROUND: Identification of transgender and gender diverse (TGD) people has been limited to diagnoses and text rather than self-identified gender identity (SIGI), representing a subset of TGD people. In 2017, the Veterans Health Administration (VHA) implemented SIGI, allowing for precise identification of TGD veterans, including subgroups (transgender man, transgender woman, and nonbinary). OBJECTIVES: Health conditions, adverse social determin…

  • Leveraging Electronic Health Record Data to Identify Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Veteran Participants in the Pride in All Who Served Program

    Guneet K Jasuja, Joel I Reisman et al.•ARTICLE•Medical Care•2025•References: 35

    BACKGROUND: Pride in All Who Served (PRIDE) is an intervention in the Veterans Health Administration (VHA) focused on enhancing Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) veterans' access to affirmative care services, social support, and engagement with VHA. Evaluation of PRIDE to date has focused on self-report data, missing critical opportunities to examine the impact of this program on health outcomes and utilization indicators de…

Medicine (6 works) · Family medicine (4 works) · Internal Medicine (4 works) · Gerontology (2 works) · Gerontology (2 works) · Hormonal and reproductive studies (2 works) · Internal Medicine (2 works) · LGBTQ Health, Identity, and Policy (2 works) · Psychiatry (2 works) · Psychology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae